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A  64-year-old woman with dyslipidemia, hyper-
tension and type 2 diabetes plus an existing 4.0-mm × 
28-mm bare-metal stent (BMS; Multilink Penta, Abbott 
Vascular, US) deployed over 10 years ago in the right 
coronary artery (RCA) was admitted to our emergency 
department with inferolateral and posterior ST-segment 
elevation acute myocardial infarction. Coronary angiog-
raphy showed occlusion and thrombotic plaque in the 
mid RCA at the site of the prior stent implantation. Af-
ter thrombectomy, optical coherence tomography (OCT) 
documented the presence of in-stent neoatherosclerosis 
with lipid-laden plaque, mild calcification, clustered mac-
rophages and a disrupted thin-cap fibroatheroma (TCFA), 
a pattern similar to the morphology seen with typical na-
tive atherosclerosis (Figure 1).
In-stent restenosis has widely been considered a sta-
ble process, showing an early peak of intimal hyperplasia 
followed by a stationary period generally after 1 year fol-
lowing stent implantation [1]. More recently, patholog-
ic and in vivo intravascular imaging studies have chal-
lenged this finding by showing that lipid-rich plaque with 
macrophage infiltration and a necrotic core may occur in-
side the stent. This process of in-stent neoatherosclerosis 
occurs within months to a few years, compared with the 
decades that it generally takes for native disease to de-
velop [2, 3]. Previous autopsy studies have shown a high-
er incidence of neoatherosclerosis in lesions treated with 
first- and second- generation drug-eluting stents (DES) 
compared with BMS (31% vs. 30% vs. 16%, respectively) 
[2, 3]. Of note, neoatherosclerosis presentation occurred 
on average at ~400 days after first-generation DES, ~200 
days after second-generation DES, and ~2,000 days af-
ter BMS [2, 3]. Much like native coronary disease, the 
infiltration of foamy macrophages within the neointima 
could possibly cause thinning of the fibrous cap, leading 
to the development of a TCFA and complications of rup-
ture with thrombosis, as seen in the present case.
The present report describes an unusual case of very, 
very late stent thrombosis – occurring more than a de-
cade after BMS at 3,710 days – with evidence of neoath-
erosclerosis. This case highlights the need for continuous 
and perpetual secondary prevention of coronary artery 
disease in patients receiving percutaneous coronary in-
tervention. The permanent presence of metallic foreign 
material in the vessel wall might indefinitely remain 
a potential trigger for stent failure at extended follow-up.
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Figure 1. RCA angiography in right anterior oblique view before (left) and after (middle) thrombus aspiration. 
The region between the arrows represents the region covered by the BMS implanted over a decade earlier. OCT 
(right) demonstrates that TCFA has developed inside the stent and caused plaque rupture and stent throm-
bosis. Arrows indicate examples of stent struts. Asterisks indicate the presence of a cavity behind the residual 
fibrous plaque. The necrotic core is seen as a  signal-poor region within the plaque, with poorly delineated 
borders, a fast signal drop-off, and low OCT backscattering covered by a high intensity signal by the fibrous cap 
(A–C). Note the presence of cholesterol crystal at 6 o’clock in panel C and white thrombus at 12 o’clock in panel 
A. A cluster of macrophages with a high signal with dorsal shadowing is seen from 9 to 12 o’clock in panel B. 
Figures on the right are replicated and zoomed
